DMHA Gets FDA Attention At Alternative Labs, CBD Noticed While There
Executive Summary
Warning doesn't reference any noncompliant claims for CBD-labeled Green Roads, but FDA explains the basis for which it has stated for two years it could warn every firm marketing products that are labeled as or found containing CBD.